Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Blanche Valnet-Rabier

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Autoimmunity Reviews|June 17, 2020
Risk of scleroderma according to the type of immune checkpoint inhibitorsBenjamin Terrier, Sébastien Humbert, Laure-Hélène Preta, et al.
European Journal of Clinical Pharmacology|June 11, 2021
REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteriaBarbara Roux, Julie Berthou-Contreras, Jean-Baptiste Beuscart, et al.
British Journal of Clinical Pharmacology|December 5, 2018
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 casesBethsabée Garel, Saskia Ingen-Housz-Oro, Daniele Afriat, et al.
Therapie|November 17, 2019
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric populationDominique Hillaire-Buys, Mégane Mousset, Marion Allouchery, et al.
Therapie|December 5, 2024
The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience reportSamuel Crommelynck, Aurélie Grandvuillemin, Claire Ferard, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Autoimmunity Reviews|June 17, 2020
Risk of scleroderma according to the type of immune checkpoint inhibitorsBenjamin Terrier, Sébastien Humbert, Laure-Hélène Preta, et al.
European Journal of Clinical Pharmacology|June 11, 2021
REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteriaBarbara Roux, Julie Berthou-Contreras, Jean-Baptiste Beuscart, et al.
British Journal of Clinical Pharmacology|December 5, 2018
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 casesBethsabée Garel, Saskia Ingen-Housz-Oro, Daniele Afriat, et al.
Therapie|November 17, 2019
Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric populationDominique Hillaire-Buys, Mégane Mousset, Marion Allouchery, et al.
Therapie|December 5, 2024
The enhanced national pharmacovigilance system implemented for COVID-19 vaccines in France: A 2-year experience reportSamuel Crommelynck, Aurélie Grandvuillemin, Claire Ferard, et al.
Pageof 4